Skip to content
Uncategorized

Texas Judge Blocks Smokeable Hemp Ban as April 28 Hearing Looms


Title: Texas Judge Blocks Smokeable Hemp Ban as April 28 Hearing Looms
Site: CBDWorldNews.com
Category: Regulation & Policy
Primary Keyword: Texas smokeable hemp ban ruling
Secondary Keywords: THCA flower Texas, hemp regulations, DSHS hemp rules, Travis County hemp lawsuit
Featured Image Search Term: Texas courthouse gavel legal proceedings
Unsplash Photo ID: SFjYRiyl3T4
Photographer: Natilyn Hicks Photography
Unsplash Attribution: Photo by Natilyn Hicks Photography on Unsplash
Meta Description: A Travis County judge blocked Texas’ smokeable hemp ban. The April 28 hearing will decide whether the injunction holds as the lawsuit continues.
Tags: Texas, hemp ban, smokeable hemp, THCA, state regulation
Word Count: 1000
Estimated Read Time: 5 minutes
Internal Links: CBDProducts.com hemp flower guide, SafeCBD.com third-party testing

Texas Judge Blocks Smokeable Hemp Ban as April 28 Hearing Looms

The state’s hemp industry hangs on today’s hearing, where Judge Maya Guerra Gamble will decide whether to extend protections against DSHS regulations that took effect March 31.

By CBDWorldNews Editorial Staff | April 28, 2026

Dek: Texas hemp businesses won a temporary reprieve from sweeping new state regulations, but the real fight starts today as a Travis County judge weighs a longer injunction.

Travis County Judge Maya Guerra Gamble temporarily blocked enforcement of Texas’ new smokeable hemp ban earlier this month, granting a temporary restraining order that paused some of the most restrictive state-level hemp regulations in the country. Today, April 28, marks the critical hearing that will determine whether those protections hold while the full lawsuit plays out.

What Texas Changed on March 31

The Texas Department of State Health Services rolled out sweeping new hemp regulations on March 31 that changed how laboratories measure total THC in products. Under the new testing methodology, THC levels are measured based on activation potential — meaning if THC content exceeds the 0.3% threshold when smoked, the product fails compliance.

That single change effectively banned THCA flower, pre-rolled joints, and other popular smokeable hemp products overnight. The regulations also introduced steep licensing fee increases for hemp retailers and manufacturers and blocked interstate sales.

The Industry Pushes Back

Hemp businesses filed suit arguing that the Department of State Health Services overstepped its authority. The core legal claim: an administrative agency cannot substitute its own policy judgment for the outcome produced by the constitutional lawmaking process. The Texas Constitution vests legislative power in the Legislature, not in administrative agencies.

Judge Guerra Gamble agreed with enough of the argument to grant a temporary restraining order that blocked the smokeable hemp ban and restored interstate sales. She left the licensing fee increases in place, deferring that issue to the April 28 hearing.

> “The question before the court is straightforward: did DSHS create new law, or did it interpret existing law? The industry says it’s the former.” — Legal analysis from the Texas Tribune

What the Ban Would Mean

Texas represents one of the largest hemp markets in the country. The smokeable hemp segment — flower, pre-rolls, and related products — generates significant revenue for small businesses throughout the state, particularly in Austin, Houston, Dallas, and San Antonio.

If the regulations stand, businesses face three immediate problems. First, their most popular product category becomes illegal to sell. Second, dramatically higher licensing fees raise the cost of staying in business. Third, the interstate sales ban cuts off revenue from out-of-state customers who previously ordered Texas-grown hemp products online.

The ripple effects extend to farmers. Texas hemp cultivators who planted crops specifically for the smokeable flower market would lose their primary buyer base within the state.

The National Context

Texas is not the only state grappling with hemp regulation, but its approach stands out for its severity and its method. While the federal government debates the November 2026 ban on hemp products exceeding 0.4 milligrams of THC per container, Texas moved to restrict products through administrative rulemaking rather than legislation.

That procedural choice is the crux of the legal challenge. If Judge Guerra Gamble rules that DSHS overstepped, it would set a precedent affecting how Texas agencies regulate hemp going forward. If the regulations survive, other state health departments could follow the same playbook.

Several other states have taken different approaches. Maryland recently passed legislation protecting veterinarians who discuss cannabis treatment options for pets, reflecting a more permissive trend. The contrast highlights how state-level hemp policy remains fractured across the country.

What to Watch Today

The April 28 hearing carries weight beyond the temporary restraining order. Judge Guerra Gamble will decide whether to convert the TRO into a longer temporary injunction that would keep the DSHS rules paused while the full lawsuit proceeds — a process that could take months.

Key questions for the hearing include whether the licensing fee increases will be blocked alongside the smokeable hemp ban, whether interstate sales protections will be extended, and how long the injunction would last if granted.

For hemp businesses currently operating under the TRO’s protection, today’s outcome determines whether they can continue selling smokeable products or need to pull inventory immediately.

Consumers looking for hemp products should verify that any products they purchase meet [third-party testing standards](https://safecbd.com/testing-verification) and carry current certificates of analysis. The regulatory uncertainty makes independent lab verification more important than ever. For a guide to [quality hemp flower products](https://cbdproducts.com/hemp-flower), current compliance status matters as much as cannabinoid content.

These statements have not been evaluated by the Food and Drug Administration. CBD products are not intended to diagnose, treat, cure, or prevent any disease.